Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сидарс-Синай Медикал СентерfiledCriticalСидарс-Синай Медикал Сентер
Priority claimed from PCT/US2020/017212external-prioritypatent/WO2020163715A1/en
Publication of EA202192172A1publicationCriticalpatent/EA202192172A1/en
Investigating Or Analysing Biological Materials
(AREA)
Abstract
В настоящем документе описаны способы, системы, композиции и наборы, пригодные для диагностики и/или лечения заболевания или состояния у субъекта. Настоящее изобретение относится к способам и системам идентификации и стратификации пациентов, подходящих для лечения модулятором IL18R1, как описано в настоящем документе.Described herein are methods, systems, compositions, and kits useful for diagnosing and/or treating a disease or condition in a subject. The present invention relates to methods and systems for identifying and stratifying patients suitable for treatment with an IL18R1 modulator as described herein.
EA202192172A2019-03-072020-02-07
METHODS, SYSTEMS AND KITS FOR TREATMENT OF INFLAMMATORY DISEASE
EA202192172A1
(en)
human monoclonal anti-lamella antibody (anti-lam) antibody, human monoclonal anti-lam antibody, human monoclonal anti-pim6 / lam antibody, kit for detecting at least one lam epitope, method for diagnosing an active tuberculosis infection in an individual, and method to treat a tuberculosis infection in an individual